Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | VX-680 | CTRPv2 | pan-cancer | AAC | -0.037 | 0.7 |
mRNA | JW-480 | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | CGP-082996 | GDSC1000 | pan-cancer | AAC | 0.018 | 0.7 |
mRNA | navitoclax:sorafenib (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.012 | 0.7 |
mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | -0.011 | 0.7 |
mRNA | Rapamycin | GDSC1000 | pan-cancer | AAC | -0.017 | 0.7 |
mRNA | BRD-K13185470 | CTRPv2 | pan-cancer | AAC | -0.023 | 0.7 |
mRNA | IU1 | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | paclitaxel | CCLE | pan-cancer | AAC | 0.016 | 0.7 |
mRNA | AEW541 | CCLE | pan-cancer | AAC | 0.016 | 0.7 |